Denise Rezende: What Should Clinicians Do When Thrombosis Occurs Despite DOAC Therapy?
Denise Rezende, Product Manager of Systems Worldwide Marketing, Hemostasis at Werfen North America, shared a post on LinkedIn:
”Great topic and a very relevant discussion!
What should clinicians do when thrombosis occurs despite DOAC therapy?
Looking forward to hearing the perspectives of international experts and learning more about the clinical management and different approaches to these challenging situations.
Another great educational initiative supported by Werfen.”
Werfen shared a post on LinkedIn:
”What should clinicians do when thrombosis occurs despite DOAC therapy?
Join the upcoming ISTH webinar, ‘Breakthrough Thrombosis in DOACs: What to do Next,’ where international experts will explore the latest perspectives on managing these challenging cases.
August 19, 2026 | 12:00 PM UTC
Werfen is proud to support educational initiatives that advance understanding in thrombosis and hemostasis.”
Stay updated with Hemostasis Today.
-
Oct 2, 2026, 09:20Anticoagulants, Blood Thinners, or Antithrombotic Medications? – World Thrombosis Day
-
Oct 2, 2026, 06:00Susan Wickersham: Gradual Shift towards Autologous Blood Transfusion is a Current Trend
-
Oct 2, 2026, 05:54Shamee Shastry: When Every Cell Reacts – The Hunt for Rare Blood
-
Oct 2, 2026, 05:49David Mclntosh: Expanding Plasma Protein Therapies in Underserved Regions
-
Oct 2, 2026, 05:38Dianne E. van der Wal: C-Terminal Endings Impact PAR1/PAR4 Peptide Potency in In Vitro Platelet Assays
-
Oct 2, 2026, 05:29Mohammed Alo: Your LDL Isn’t a Snapshot – It’s a Smoking Habit Measured in Years
-
Oct 2, 2026, 00:33Marwa Mostafa: Hemoglobinopathies – When Globin Genes Go Wrong
-
Oct 1, 2026, 23:46Behnood Bikdeli: Global Burden of Venous Thromboembolism
-
Oct 1, 2026, 23:46Sthanu Subramanian: Clinical Presentation, Risk Factors, Diagnosis, and Neuroimaging Findings in CVT